- Company Overview for AXALBION THERAPEUTICS LIMITED (13224059)
- Filing history for AXALBION THERAPEUTICS LIMITED (13224059)
- People for AXALBION THERAPEUTICS LIMITED (13224059)
- Charges for AXALBION THERAPEUTICS LIMITED (13224059)
- More for AXALBION THERAPEUTICS LIMITED (13224059)
- Registered office address
- C/O Medicines Evaluation Unit, The Langley Building, Southmoor Road, Wythenshawe, Manchester, United Kingdom, M23 9QZ
- Company status
- Active
- Company type
- Private limited Company
- Incorporated on
- 24 February 2021
Accounts
Next accounts made up to 31 December 2023
due by
31 December 2024
Last accounts made up to 31 December 2022
Confirmation statement
Next statement date 15 May 2025
due by 29 May 2025
Last statement dated 15 May 2024
Nature of business (SIC)
- 21100 - Manufacture of basic pharmaceutical products